RMTI Rockwell Medical Inc.

6.52
+0.07  (1%)
Previous Close 6.45
Open 6.52
Price To book 8.25
Market Cap 337481981
Shares 51,761,040
Volume 26,281
Short Ratio 33.14
Av. Daily Volume 279,822

SEC filingsSee all SEC filings

  1. 10-Q - Quarterly report [Sections 13 or 15(d)] 171187368
  2. 8-K - Current report 171186526
  3. 8-K/A [Amend] - Current report 171111593
  4. 8-K/A [Amend] - Current report 171079080
  5. 8-K - Current report 171079054

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approved January 26, 2015.
Soluble Ferric Pyrophosphate
Iron deficiency

Latest News

  1. ETFs with exposure to Rockwell Medical, Inc. : November 14, 2017
  2. Edited Transcript of RMTI earnings conference call or presentation 8-Nov-17 9:30pm GMT
  3. Rockwell Medical, Inc. :RMTI-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017
  4. Rockwell Medical reports 3Q loss
  5. Rockwell Medical Reports Third Quarter Results
  6. Rockwell Medical Schedules Third Quarter 2017 Earnings Call
  7. Rockwell Medical Announces Two Triferic Poster Presentations at American Society of Nephrology Kidney Week 2017 Annual Meeting
  8. Rockwell Medical, Inc. – Value Analysis (NASDAQ:RMTI) : October 25, 2017
  9. Rockwell Update on Calcitriol Post-Approval Manufacturing Submission to FDA
  10. Rockwell Medical, Inc. breached its 50 day moving average in a Bearish Manner : RMTI-US : October 24, 2017
  11. ETFs with exposure to Rockwell Medical, Inc. : October 16, 2017
  12. Rockwell Files Calcitriol Post-Approval Manufacturing Submission with FDA
  13. ETFs with exposure to Rockwell Medical, Inc. : September 22, 2017
  14. Rockwell Medical, Inc. :RMTI-US: Earnings Analysis: Q2, 2017 By the Numbers : September 21, 2017
  15. Rockwell Medical, Inc. breached its 50 day moving average in a Bullish Manner : RMTI-US : September 21, 2017
  16. Rockwell Medical Updates Progress on Calcitriol Commercial Launch
  17. Richmond Brothers Comments on Appointment of John G. Cooper to Rockwell Medical, Inc. Board
  18. Rockwell Medical Appoints John G. Cooper to Board of Directors
  19. Richmond Brothers and Mark H. Ravich Issue Statement on Rockwell Medical, Inc.

SEC Filings

  1. 10-Q - Quarterly report [Sections 13 or 15(d)] 171187368
  2. 8-K - Current report 171186526
  3. 8-K/A [Amend] - Current report 171111593
  4. 8-K/A [Amend] - Current report 171079080
  5. 8-K - Current report 171079054
  6. CT ORDER - Confidential treatment order 171059265
  7. SC 13D/A [Amend] - General statement of acquisition of beneficial ownership 171055501
  8. 10-Q - Quarterly report [Sections 13 or 15(d)] 171018712
  9. 8-K - Current report 171018242
  10. 8-K - Current report 17938992